Invesco Pharmaceuticals ETF Rating $81.92 +1.06 (+1.31%) As of 05/2/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock Invesco Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PJP Aggregate RatingModerate Buy 2.69Holdings in PJP have an aggregate rating of Moderate Buy based on 389 analyst ratings issued in the past year covering 30 companies (99.8% of the portfolio).PJP Aggregate Price Target$81.92High Prediction$81.92Average Prediction$81.92Low Prediction$81.92Holdings in PJP have an aggregate price target of $81.92 and a range of $81.92 to $81.92 covering 30 companies (99.8% of the portfolio).PJP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 30 PJP Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.34%ABTAbbott Laboratories$132.92+1.6%4.9034 of 5 stars2.84$142.59 7.3%19Insider TradePositive News5.30%GILDGilead Sciences$103.68+0.4%4.896 of 5 stars2.78$110.55 6.6%27Dividend AnnouncementPositive News5.22%JNJJohnson & Johnson$156.09+1.1%4.7194 of 5 stars2.63$171.82 10.1%19Analyst RevisionPositive News5.20%AMGNAmgen$281.22-0.9%4.0826 of 5 stars2.41$308.18 9.6%22Earnings ReportAnalyst ForecastAnalyst RevisionNews CoveragePositive NewsGap Up4.97%ABBVAbbVie$198.62+2.7%4.6041 of 5 stars2.89$211.41 6.4%27Earnings ReportAnalyst ForecastAnalyst RevisionPositive News4.95%MRKMerck & Co., Inc.$83.14-0.1%5 of 5 stars2.59$111.13 33.7%22Insider TradeAnalyst RevisionPositive News4.71%PFEPfizer$24.19+1.1%4.9814 of 5 stars2.53$29.17 20.6%15Earnings ReportAnalyst ForecastAnalyst Revision4.66%LLYEli Lilly and Company$825.10+3.9%4.9205 of 5 stars2.81$1,002.80 21.5%21Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap Up3.80%ANIPANI Pharmaceuticals$72.95+3.2%3.8657 of 5 stars3.00$80.13 9.8%9Upcoming Earnings3.52%CORTCorcept Therapeutics$72.77+1.8%4.8045 of 5 stars3.00$143.25 96.9%5Short Interest ↓News CoveragePositive NewsGap Up3.40%TARSTarsus Pharmaceuticals$47.36-5.8%2.1966 of 5 stars3.00$64.67 36.5%7Earnings ReportUpcoming EarningsAnalyst ForecastNews CoveragePositive NewsGap Down3.07%PRGOPerrigo$25.65+1.5%4.8774 of 5 stars2.25$33.00 28.7%4Upcoming EarningsDividend AnnouncementShort Interest ↑Positive News3.02%INVAInnoviva$18.72+0.4%4.2171 of 5 stars3.00$55.00 193.8%2Upcoming EarningsAnalyst UpgradeNews CoveragePositive News3.01%SUPNSupernus Pharmaceuticals$32.84+1.2%2.2515 of 5 stars2.33$36.00 9.6%3Upcoming Earnings3.00%PCRXPacira BioSciences$26.45-1.1%1.9214 of 5 stars2.33$26.67 0.8%9Upcoming Earnings2.94%PBHPrestige Consumer Healthcare$84.23+2.4%4.0573 of 5 stars2.50$93.33 10.8%6Upcoming EarningsAnalyst UpgradeNews Coverage2.76%BMYBristol-Myers Squibb$50.56+1.9%4.7014 of 5 stars2.32$58.00 14.7%22Insider TradeAnalyst Revision2.72%COLLCollegium Pharmaceutical$27.65+2.2%3.9544 of 5 stars2.80$43.60 57.7%5Upcoming EarningsNews CoveragePositive News2.71%LGNDLigand Pharmaceuticals$109.39+0.2%4.3898 of 5 stars3.00$146.43 33.9%7Upcoming Earnings2.61%AMRXAmneal Pharmaceuticals$7.97+3.0%3.3146 of 5 stars3.00$10.80 35.5%5Earnings ReportNews CoveragePositive NewsHigh Trading Volume2.55%LQDALiquidia$15.83+13.2%2.8782 of 5 stars3.11$26.63 68.2%9News CoveragePositive NewsHigh Trading Volume2.51%BIIBBiogen$123.53+2.2%4.695 of 5 stars2.38$195.85 58.5%32Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage2.49%HRMYHarmony Biosciences$30.32+1.5%4.8627 of 5 stars3.00$52.44 73.0%9Upcoming EarningsAnalyst RevisionNews CoveragePositive NewsGap Up2.48%UTHRUnited Therapeutics$294.60+0.3%4.9881 of 5 stars2.67$392.00 33.1%12Earnings ReportAnalyst ForecastInsider TradeNews CoveragePositive News2.40%REGNRegeneron Pharmaceuticals$605.61+2.6%4.8316 of 5 stars2.88$892.60 47.4%26Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume2.34%AMPHAmphastar Pharmaceuticals$24.50+2.6%4.4867 of 5 stars2.00$43.50 77.6%3Upcoming EarningsNews CoveragePositive News2.32%JAZZJazz Pharmaceuticals$120.05+2.4%4.8017 of 5 stars2.93$187.71 56.4%14Upcoming EarningsAnalyst RevisionNews Coverage2.08%TVTXTravere Therapeutics$21.15+1.9%2.8993 of 5 stars2.87$31.79 50.3%15Earnings ReportAnalyst ForecastNews Coverage2.01%VTRSViatris$8.65+2.1%1.5296 of 5 stars1.75$10.50 21.4%4Upcoming EarningsGap Up1.74%GERNGeron$1.38-3.5%3.9884 of 5 stars2.89$5.38 289.5%9Upcoming Earnings This page (NYSEARCA:PJP) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PJP Stock Free PJP Stock Alerts